Austral Dx raises €2.5 million to reinvent cardiopulmonary diagnostics
24 July 2025 • Sorbonne Venture, Venture Deeptech • Back to news
Austral Dx, a deep tech startup founded in 2021, has announced that it has raised €2.5 million in funding to accelerate the development of its contactless medical device, which can assess cardiopulmonary health in less than two minutes using artificial intelligence and airborne ultrasound.
The round table brings together Sorbonne Venture by Audacia, Aloe Private Equity, iXCore, Kima Ventures, Better Angle, Super Capital, several business angel clubs, as well as a government grant via the i-Nov – France 2030 competition.
This funding will enable Austral Dx to launch a multicenter clinical trial, finalize its prototype, and aim for ISO 13485 certification, with the ambition of becoming a key player in cardiopulmonary diagnostics.